Institution · National Oncologic Institute

Most cited papers from National Oncologic Institute

National Oncologic Institute

What are the most cited papers from National Oncologic Institute?

The most cited paper from National Oncologic Institute is "2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial" (Ian Smith et al., 2007), with 1,521 citations. Next come "Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial" (780) and "Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)" (197).

Published TypeFieldAccessCitations

Showing 50 of 61 papers. Every paper with more than 4 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Ian Smith et al. · The Lancet	2007	1,521
2	Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial Yoon‐Koo Kang, Won Ki Kang, D.B. Shin et al. · Annals of Oncology Open access	19 Jan 2009	780
3	Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) Oscar G. Arrieta, Andrés Felipe Cardona, Claudio Marcelo Martin et al. · Journal of Thoracic Oncology Open access	28 Jan 2015	197
4	PARITY AS A RISK FACTOR FOR CERVICAL CANCER Louise Annette Brinton, William C. Reeves, Maria Majela Brenes et al. · American Journal of Epidemiology	Sep 1989	197
5	Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population Rolando Herrero, Louise Annette Brinton, William C. Reeves et al. · Cancer Open access	15 Jan 1990	158
6	A Case-Control Study of Nutrient Status and Invasive Cervical Cancer Rolando Herrero, Nancy A. Potischman, Louise Annette Brinton et al. · American Journal of Epidemiology	Dec 1991	141
7	The ma le factor in the etiology of cervical cancer among sexually monogamous women Louise Annette Brinton, William C. Reeves, Maria Majela Brenes et al. · International Journal of Cancer	15 Aug 1989	131
8	Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE Eleftherios P. Mamounas et al. · Annals of Oncology Open access	28 Apr 2021	128
9	Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation David W. Miles, David Cameron, Igor Bondarenko et al. · European Journal of Cancer	4 Nov 2016	126
10	Oral Contraceptive Use and Risk of Invasive Cervical Cancer Louise Annette Brinton, William C. Reeves, Maria Majela Brenes et al. · International Journal of Epidemiology	1990	123
11	Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward Carlos H. Barrios et al. · The Lancet Oncology	Nov 2021	117
12	Screening for Cervical Cancer in Latin America: A Case-Control Study Rolando Herrero, Louise Annette Brinton, William C. Reeves et al. · International Journal of Epidemiology	1992	105
13	Psychometric Properties of a Spanish Version of the McGill Pain Questionnaire in Several Spanish-Speaking Countries Carlos Gallego Lázaro, Xavier Caseras, Víctor M. Whizar-Lugo et al. · Clinical Journal of Pain	Dec 2001	99
14	Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases Juan Carlos Alcedo, José Manuel Fábrega, Juan Ramón Arosemena et al. · Head & Neck	3 Aug 2004	95
15	A Case-Control Study of Nutrient Status and Invasive Cervical Cancer Nancy A. Potischman, Rolando Herrero, Louise Annette Brinton et al. · American Journal of Epidemiology	Dec 1991	93
16	Risk Factors for Cervical Cancer by Histology Louise A. Brinton, Rolando Herrero, William C. Reeves et al. · Gynecologic Oncology	Dec 1993	83
17	Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers Allan Hildesheim, William C. Reeves, Louise Annette Brinton et al. · International Journal of Cancer	15 May 1990	75
18	Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma Prakash SS, William C. Reeves, Gary R. Sisson et al. · International Journal of Cancer	15 Jan 1985	74
19	Invasive Cervical Cancer and Smoking in Latin America Rolando Herrero, Louise Annette Brinton, William C. Reeves et al. · JNCI Journal of the National Cancer Institute	Feb 1989	69
20	Case‐control study of human papillomaviruses and cervical cancer in Latin America William C. Reeves, Deoraj Caussy, Louise Annette Brinton et al. · International Journal of Cancer	15 Oct 1987	67
21	EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) Andrés Felipe Cardona et al. · Lung Cancer	9 Oct 2018	62
22	Latin America: the next region for haematopoietic transplant progress Gregorio Jaimovich et al. · Bone Marrow Transplantation Open access	23 Jan 2017	59
23	Case control study of cervical cancer in Herrera Province, Republic of Panama William C. Reeves, Louise Annette Brinton, Maria Majela Brenes et al. · International Journal of Cancer	15 Jul 1985	51
24	Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association Rolando Herrero, Louise Annette Brinton, William C. Reeves et al. · International Journal of Cancer	15 Jul 1990	46
25	Human papillomaviruses and other influences on survival from cervical cancer in Panama. R. C. Debritton, Allan Hildesheim, S. Lao et al. · PubMed	1993	45
26	Cancer Immunotherapy-Associated Hypophysitis Franklin Castillero, O. Castillo, Geiner Jiménez Jiménez et al. · Future Oncology Open access	19 Aug 2019	42
27	Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework) Carolina Espina et al. · Cancer Epidemiology Open access	Oct 2023	39
28	Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity Carlos Axel López-Pérez, Xochitl Franco-Mojica, Ricardo Villanueva-Gaona et al. · Journal of Neuro-Oncology	14 May 2022	39
29	An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP) Luis Corrales, Oscar G. Arrieta, Luis A. Mas et al. · Lung Cancer	11 Sep 2017	33
30	The relations between cervical cancer and serological markers of nutritional status Nancy A. Potischman, Robert N. Hoover, Louise Annette Brinton et al. · Nutrition and Cancer	1994	33
31	Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial István Láng, R. Bell, Fan Feng et al. · Clinical Oncology	17 Sep 2013	29
32	The Endless Vulnerability of Migrant Children In-Transit across the Darién Gap Laura Menéndez Naranjo, Yesenia Williams, Jacqueline Levy et al. · American Journal of Tropical Medicine and Hygiene Open access	24 Jul 2023	26
33	The paradox of haematopoietic cell transplant in Latin America Gregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman et al. · Bone Marrow Transplantation	13 May 2021	24
34	Chemotherapy in patients with advanced pancreatic cancer: too close to death? Mauro Frigeri, Sara De Dosso, O. Castillo et al. · Supportive Care in Cancer	30 May 2012	20
35	CERVICAL CANCER IN THE REPUBLIC OF PANAMA William C. Reeves, Maria Majela Brenes, Rosa C. de Britton et al. · American Journal of Epidemiology	May 1984	19
36	BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival Kátia Bórgia Barbosa Pagnano et al. · Cancer Investigation Open access	17 Aug 2015	19
37	The Hispanic Paradox in Non-Small Cell Lung Cancer Rohit Kumar, Franklin Castillero, Shruti Bhandari et al. · Hematology/Oncology and Stem Cell Therapy Open access	11 Mar 2021	18
38	Status of breast cancer in Latin American: Results of the breast cancer revealed initiative Natalia Ayala et al. · Critical Reviews in Oncology/Hematology	30 Nov 2022	16
39	Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice Agustin Horacio Falco, Thiago Bueno de Oliveira, Jon Cacicedo et al. · Cancer Management and Research Open access	Aug 2021	16
40	Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016 Roberto Ivan Lopez, Jenny Lissette Castro, Heidy Cedeño et al. · ESMO Open Open access	2018	15
41	Alternative management for gynecological cancer care during the COVID‐2019 pandemic: A Latin American survey Juliana Rodríguez et al. · International Journal of Gynecology & Obstetrics Open access	11 Jun 2020	14
42	Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices Claudio Marcelo Martin, Andrés Felipe Cardona, Zyanya Lucía Zatarain-Barrón et al. · Oncology	2018	12
43	Clinical effects in a cohort of cancer patients overexposed during external beam pelvic radiotherapy Cari Borrás, Juan Pablo Barés, Damian Rudder et al. · International Journal of Radiation OncologyBiologyPhysics	14 May 2004	12
44	Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study Franz Castro, David Shahal, Musharaf Tarajia et al. · BMJ Open Open access	Sep 2017	10
45	Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America Virginia Bove, Eloísa Riva, Jule F Vasquez et al. · JCO Global Oncology Open access	Jul 2022	9
46	Gliomatosis cerebri: características clinicopatológicas, de neuroimagen y resultados del tratamiento con radioterapia Iván Mena Blacio, Diego A. Olivares, Óscar H. Del Brutto et al. · Revista de Neurología	2000	8
47	Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer Carlos Bonilla, Paola Montenegro, Juan Manuel O’Connor et al. · Cancers Open access	Sep 2023	7
48	Neuroendocrine tumors in Panama: A nationwide database analysis Moisés Cukier, Ruth Vergara, Jorge David Mendez-Rios et al. · Molecular and Clinical Oncology Open access	11 Jun 2021	7
49	Estudio de Pertinencia de los Cuidados Paliativos en Ecuador. Mariana Vallejo Martínez, Nancy Lino, Rina Quinto · Oncología (Ecuador) Open access	30 Dec 2017	7
50	Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC) M. Untch, Charles E. Geyer, C. Huang et al. · Annals of Oncology Open access	Nov 2019	6

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.